Merck & Co., Inc., Kenilworth NJ USA Provides New Funding to Fight HIV/AIDS in Botswana | Bill & Melinda Gates Foundation

WHITEHOUSE STATION, N.J. -- Merck & Co., Inc., Kenilworth NJ USA today announced the Merck Company Foundation and the Bill & Melinda Gates Foundation are committing an additional $60 million to support Botswana’s African Comprehensive HIV/AIDS Partnerships (ACHAP). Merck & Co., Inc., Kenilworth NJ USA is known as MSD outside the US and Canada. A unique program developed with and led by the Government of Botswana, ACHAP is one of sub-Saharan Africa’s oldest, most successful public-private partnerships. With today’s pledge, the Merck Foundation and the Gates Foundation’s total cash contributions now amount to $166.5 million. Merck & Co., Inc., Kenilworth NJ USA will also continue the donation of its HIV medicines.

To read the full press release, visit Merck & Co., Inc., Kenilworth NJ USA's web site.